_:vb50940933	<http://www.w3.org/2002/07/owl#annotatedProperty>	<http://purl.obolibrary.org/obo/IAO_0000115> .
_:vb50940933	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/2002/07/owl#Axiom> .
_:vb50940933	<http://www.w3.org/2007/05/powder-s#describedby>	<https://demo.openlinksw.com/about/id/entity/http/purl.obolibrary.org/obo/doid.owl> .
_:vb50940933	<http://www.w3.org/2002/07/owl#annotatedSource>	<http://purl.obolibrary.org/obo/DOID_0080431> .
_:vb50940933	<http://purl.org/dc/elements/1.1/type>	<http://purl.obolibrary.org/obo/ECO_0007645> .
_:vb50940933	<http://www.geneontology.org/formats/oboInOwl#hasDbXref>	"url:https://www.ncbi.nlm.nih.gov/pubmed/24623842"^^<http://www.w3.org/2001/XMLSchema#string> .
_:vb50940933	<http://www.w3.org/2002/07/owl#annotatedTarget>	"A developmental and epileptic encephalopathy characterized by onset of seizures in the first year of life and mild to moderate impaired intellectual development that has_material_basis_in heterozygous mutation in the GABRA1 gene on chromosome 5q34."^^<http://www.w3.org/2001/XMLSchema#string> .